Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for growth.

The Cannabist Co. will sell its vertically integrated permit in Virginia to a Boston-based hedge fund rather than competing ...

The U.S. cannabis industry continued to pullback in the third quarter of 2025, according to licensing data from intelligence ...

Cannabis' sworn enemy revealed itself to be behind the voter initiative campaigns seeking to roll back $1.9 billion in annual sales.

Marijuana rescheduling isn't official yet. Here's what needs to happen for cannabis to be downgraded under federal law.

Cannabis will be moved to Schedule 3 of the Controlled Substances Act under an executive order President Donald Trump signed Thursday.

Cannabis and hemp THC companies stand to benefit if marijuana is reclassified to Schedule 3, but banking and investment needs more reform.

President Donald Trump's order to reclassify cannabis as a Schedule 3 drug is a huge step forward - but operators must know its limits.

New Jersey legislators are moving forward with a bill that could reshape the state’s market for hemp-derived cannabinoids.

Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly issued ...

President Donald Trump's executive order reclassifying cannabis as a Schedule 3 drug could come Monday - and with it, Medicare coverage for CBD.